Yorkville Advisors

Plug Power Inc. is a leading provider of hydrogen fuel cell solutions, focusing on clean and zero-emission technologies for electric mobility and stationary power markets in North America and Europe. The company specializes in proton exchange membrane (PEM) fuel cell systems, fuel processing technologies, and hybrid solutions, alongside the necessary hydrogen storage and dispensing infrastructure. Its products include GenDrive, a hydrogen-powered PEM fuel cell system for material handling vehicles; GenFuel, which encompasses hydrogen delivery and dispensing; GenCare, a maintenance program for its fuel cell systems; and GenSure, a stationary fuel cell solution for backup and grid-support power. Plug Power also offers the GenKey solution, which integrates all essential components for fuel cell power, and ProGen, a fuel cell stack technology used in various applications. With over 40,000 deployed fuel cell systems, Plug Power is a significant player in the hydrogen economy and has established a network of hydrogen highways across North America. Founded in 1997 and headquartered in Latham, New York, the company serves a diverse clientele, including major corporations and industries.

Vivoryon Therapeutics AG is a clinical stage biopharmaceutical company based in Halle, Germany, specializing in the research and development of therapeutic products for Alzheimer's disease and cancer. The company's lead candidate, PQ912, is a small molecule QC inhibitor that has completed Phase IIb clinical trials for Alzheimer's disease and is also being explored for cancer treatment. Additionally, Vivoryon is developing PQ1565, a small molecule inhibitor targeting glutaminyl-peptide cyclotransferase-like for cancer therapy, along with a monoclonal antibody aimed at enhancing the clearance of toxic pyroglutamate-Abeta. The company collaborates with various institutions, including the University Medical Center Schleswig-Holstein and Nordic Bioscience, to advance its clinical and research initiatives. Originally founded in 1997 as Probiodrug AG, the company rebranded to Vivoryon Therapeutics AG in June 2019.

Lytus Technologies Holdings is a platform services company based in India that specializes in content streaming and telecasting services. In addition to its core offerings, the company provides telemedicine services, facilitated by local health centers to enhance accessibility to healthcare. Lytus connects its customers through customer premises equipment (CPE) devices, such as set-top boxes (STBs), ensuring a comprehensive range of services that includes both entertainment and health-related solutions. Its extensive customer base and strong market presence allow Lytus to diversify its product portfolio effectively, catering to a wide array of consumer needs.

Quantum Corp. is a global specialist in backup, recovery, and archive solutions trusted by over 50,000 customers worldwide. Their best-of-breed, open systems platforms, including DXi-Series for fast backup and restore, Scalar for disaster recovery and data retention, and StorNext for high-performance file sharing and archiving, offer significant storage efficiencies and cost savings while minimizing risk. Quantum helps businesses of all sizes address their data protection, retention, and management challenges with scalable and efficient solutions.

Kraig Biocraft Laboratories, Inc. is a biotechnology company that specializes in the development of protein-based fibers through recombinant DNA technology. Founded in 2006 and based in Ann Arbor, Michigan, the company focuses on creating high-performance textiles for various commercial applications, particularly in the textile, specialty fiber, and technical textile industries. Its notable products include Monster Silk, which offers enhanced flexibility due to the natural elasticity of spider silk, and Dragon Silk, which combines the qualities of Monster Silk with additional strength derived from native spider silk. Kraig Biocraft Laboratories aims to address practical challenges in the textile market through innovative solutions and advanced genetic research.

FibroBiologics, based in Houston, Texas, is a clinical-stage regenerative medicine company specializing in fibroblast-based therapies aimed at treating chronic diseases with significant unmet medical needs. The company is focused on developing innovative solutions for conditions such as degenerative disc disease, multiple sclerosis, wound healing, and certain cancers. FibroBiologics holds over 150 U.S. and international patents, covering various clinical pathways, and is positioned as a leader in the advancement of cell therapy. The company's research also explores potential applications in extending life through thymic and splenic involution reversal.

Northwest Biotherapeutics, Inc. is a biotechnology company based in Bethesda, Maryland, focused on developing personalized immune therapies for cancer. Founded in 1996, the company utilizes its proprietary DCVax platform, which leverages activated dendritic cells to stimulate the patient's immune system to target and attack cancer cells. Northwest Biotherapeutics is advancing several product candidates, including DCVax-L, currently in Phase III clinical trials for glioblastoma multiforme, and DCVax-Direct, in Phase I/II trials for various inoperable solid tumors. The company aims to offer effective cancer treatments that not only extend survival and time to recurrence but also enhance the quality of life for patients with minimal side effects compared to traditional therapies.

Baijiayun is a Chinese company specializing in cloud-based audio and video technology solutions for various sectors, including education, finance, healthcare, and government. It offers a comprehensive suite of products such as live broadcast services, on-demand video, dual-teacher classrooms, and online training systems. The company also provides advanced solutions incorporating video AI and smart learning technologies, catering to a wide range of applications, from large-scale open classes to internal corporate training and online conferences. Baijiayun is recognized for its extensive intellectual property portfolio and core technologies, positioning it as a leader in the video technology market within China, with a focus on facilitating innovation and expansion for enterprises through its one-stop service offerings.

Armlogi Holding Corp is a U.S.-based logistics company specializing in warehouse management and order fulfillment for cross-border e-commerce merchants targeting the U.S. market. It operates twelve modern warehouses, totaling 2.5 million square feet, adhering to ISO 9001 quality standards. These facilities are equipped with advanced technology and specialized equipment to handle large and bulky items efficiently and securely. Armlogi's comprehensive services include customs brokerage, transportation to U.S. warehouses, and order fulfillment.

Powell Max Limited is a financial printing and communication services company that specializes in providing financial communication and printing services. The company focuses on producing essential financial documents, such as initial public offering prospectuses, which serve as key communication tools between issuers and investors. Their services include meticulous typesetting and preparation of these documents for primary market customers.

Powell Max Limited is a financial printing and communication services company that specializes in providing financial communication and printing services. The company focuses on producing essential financial documents, such as initial public offering prospectuses, which serve as key communication tools between issuers and investors. Their services include meticulous typesetting and preparation of these documents for primary market customers.

Soluna is a U.S.-based company focused on developing green data centers that utilize wasted renewable energy for batchable computing. By integrating renewable power generation with blockchain computing facilities, Soluna aims to provide a low-cost and environmentally sustainable solution for cryptocurrency mining and other high-density computational tasks. The company is dedicated to building infrastructure that supports the blockchain economy while minimizing environmental impact. Soluna's strategy includes constructing dedicated renewable energy power plants to supply its computing centers, enabling a unique vertical integration model within the blockchain ecosystem. This approach allows Soluna to achieve operational efficiencies and position itself as a key player in the evolving landscape of renewable energy and blockchain technology.

Brand Engagement Network is an advertising company that specialises in conversational AI interfaces, consumer engagement, and digital assistance, providing human-like interactions and safe environments through multi-modal communication. Its mission is to create the best AI Assistants, making them helpful, creative, clever, and friendly. With a vision to empower people and shape the future of intelligent digital assistants.

ImmunoPrecise Antibodies Ltd. is a biotherapeutic research and technology company specializing in the production of custom antibodies and related services. Headquartered in Fargo, North Dakota, the company operates in the United States, Canada, Europe, and internationally. Its extensive service offerings include B cell sorting, phage display production, transgenic animal models, and various antibody engineering techniques. The company has developed a reputation for its advanced capabilities in antibody discovery and development, leveraging systems biology, multi-omics modeling, and artificial intelligence to enhance efficiency and accuracy. ImmunoPrecise Antibodies engages in collaborations with academic and research institutions, including partnerships aimed at developing antibody-based tests for COVID-19 and neutralizing antibodies against SARS-CoV-2. Founded in 1989, the company continues to contribute to the advancement of novel biologics and therapeutic solutions for challenging diseases.

Wearable Devices Ltd. is a company based in Kiryat Tivon, Israel, specializing in the development and manufacture of a touch-free wearable controller known as Mudra. This innovative wristband enables users to interact with digital devices, including augmented reality, virtual reality headsets, smart devices, and consumer electronics, through subtle finger movements and hand gestures without physical contact. Founded in 2014, the company has transitioned from research and development to commercialization, offering products for both business-to-business and business-to-consumer markets. The Mudra platform integrates proprietary sensors and artificial intelligence algorithms, setting new standards for user interaction in digital environments.

NioCorp Developments Ltd., established in 1987 and headquartered in Centennial, Colorado, is a mineral exploration and development company focused on North America. It specializes in the exploration and development of mineral deposits, with a primary focus on the Elk Creek niobium/scandium/titanium project located in Southeastern Nebraska. This project is notable for being the highest-grade niobium project under development in North America and the second-largest indicated or inferred rare earth mineral resource in the United States. NioCorp's planned products, including niobium, scandium, titanium, and magnetic rare earths, are all considered critical by the U.S. government and play vital roles in clean technologies and the global energy transition.

Zapp is a UK company that designs, manufactures and sells high performance electric vehicles. Our founders are automotive professionals from all over the world who share a commitment to sustainability, a long passion for electric vehicles, motorcycles, and believe in the choice of personal urban mobility. In 2017, we assembled a team of talented designers and engineers to help us realize this vision to design and manufacture electric vehicles. Superbike Performance. Scooter Accessible. Simply Electric. No Compromise.

Scilex Holding Co is a pharmaceutical company specializing in acquiring and commercializing late-stage prescription products focused on non-opioid pain management. Its primary product, ZTlido, is a topical lidocaine system used to relieve nerve pain associated with postherpetic neuralgia. Additionally, Scilex is developing Gloperba, an oral colchicine solution for preventing painful gout flares in adults. The company's pipeline includes SP-102, a viscous gel formulation of a corticosteroid for epidural injections, and SP-103, a Phase 2 triple-strength capsaicin cream for neuropathic pain.

Cardio Diagnostics is a biotechnology company based in Coralville, Iowa, focused on enhancing the prevention and early detection of cardiovascular disease. Founded in 2017, the company utilizes machine learning and DNA-based solutions to create a proprietary artificial intelligence-driven integrated Genetic-Epigenetic Engine. This innovative approach aims to make heart disease prevention more accessible, personalized, and precise, positioning Cardio Diagnostics as a leader in medical technology for improving cardiovascular health outcomes.

Kraig Biocraft Laboratories, Inc. is a biotechnology company that specializes in the development of protein-based fibers through recombinant DNA technology. Founded in 2006 and based in Ann Arbor, Michigan, the company focuses on creating high-performance textiles for various commercial applications, particularly in the textile, specialty fiber, and technical textile industries. Its notable products include Monster Silk, which offers enhanced flexibility due to the natural elasticity of spider silk, and Dragon Silk, which combines the qualities of Monster Silk with additional strength derived from native spider silk. Kraig Biocraft Laboratories aims to address practical challenges in the textile market through innovative solutions and advanced genetic research.

Faraday Future is a design and technology company focused on revolutionizing the transportation sector through innovative solutions. The company aims to address the evolving needs of consumers by integrating advancements in energy, artificial intelligence, and shared mobility. By blurring the lines between the automotive industry and technology sectors, Faraday Future seeks to create a global ecosystem that redefines transportation, content, and vehicle ownership. Their approach reflects a response to modern challenges such as urban congestion and changing lifestyles, emphasizing a commitment to developing vehicles that align with contemporary demands.

NioCorp Developments Ltd., established in 1987 and headquartered in Centennial, Colorado, is a mineral exploration and development company focused on North America. It specializes in the exploration and development of mineral deposits, with a primary focus on the Elk Creek niobium/scandium/titanium project located in Southeastern Nebraska. This project is notable for being the highest-grade niobium project under development in North America and the second-largest indicated or inferred rare earth mineral resource in the United States. NioCorp's planned products, including niobium, scandium, titanium, and magnetic rare earths, are all considered critical by the U.S. government and play vital roles in clean technologies and the global energy transition.

Kinarus AG is a biopharmaceutical company based in Basel, Switzerland, focused on developing innovative medicines targeting stress-related inflammatory processes. The company employs a cross-disease area approach to assess therapeutic targets, aiming to create differentiated treatments that address unmet medical needs. By leveraging its expertise in biopharmaceutical development, Kinarus AG strives to contribute to improved health outcomes in patients suffering from various inflammatory conditions.

D-Wave Systems Inc. specializes in the development and integration of superconducting quantum computers. As the first commercial supplier of quantum computers, the company offers products such as The D-Wave Two System, D-Wave Hybrid—a hybrid workflow platform for quantum-classical applications—and Leap, a cloud-based service that enables real-time access to quantum computing resources along with open-source development tools and educational materials. D-Wave's quantum computers are applied across various sectors, including defense, finance, energy, and academia, addressing challenges in mission planning, logistics, machine learning, optimization problems, and more. In addition to its quantum computing systems, the company provides professional services, training, and customer support to enhance user experience. Founded in 1999 and headquartered in Burnaby, Canada, D-Wave has expanded its presence with sales offices in the United States, Europe, and Asia.

Canoo is a mobility technology company that specializes in developing electric vehicles designed to transform the automotive industry through innovative design and technology. The company has created a proprietary modular electric vehicle platform that maximizes interior space and can be adapted for various applications, catering to both consumer and commercial markets. With a focus on serving commercial fleets, government, and military customers, Canoo aims to deliver new products efficiently and cost-effectively, allowing for rapid iteration and addressing diverse use cases. The company's experienced team, comprised of over 350 professionals from leading technology and automotive sectors, drives its mission to prioritize customer needs and redefine vehicle ownership models.

Virgin Orbit, LLC is a vertically integrated space company based in Long Beach, California, and incorporated in 2016. As a subsidiary of Virgin.com Limited, it specializes in providing dedicated launch services for small satellites, catering to both commercial and government entities. The company operates the LauncherOne system, which offers flexible launch capabilities tailored specifically for small satellites. Virgin Orbit’s services encompass the delivery of satellites into orbit for a range of customers across various sectors, including commercial, civil, and national security. By focusing on democratizing access to space, Virgin Orbit aims to enhance opportunities for research, private astronaut flights, and satellite deployment, ultimately benefiting life on Earth.

Bird is a micro-mobility company that specializes in designing a vehicle-sharing platform focused on providing affordable and sustainable transportation solutions. The platform facilitates access to shared personal electric vehicles, including e-scooters and electric bicycles, which can be easily picked up and dropped off at various locations. By collaborating with cities, Bird aims to enhance urban mobility, reduce car trips, alleviate traffic congestion, and lower carbon emissions. Operating in multiple locations, including over ten cities in Canada, Bird emphasizes accessibility and environmentally friendly transport options, appealing to communities seeking reliable alternatives to traditional motor vehicles.

Kraig Biocraft Laboratories, Inc. is a biotechnology company that specializes in the development of protein-based fibers through recombinant DNA technology. Founded in 2006 and based in Ann Arbor, Michigan, the company focuses on creating high-performance textiles for various commercial applications, particularly in the textile, specialty fiber, and technical textile industries. Its notable products include Monster Silk, which offers enhanced flexibility due to the natural elasticity of spider silk, and Dragon Silk, which combines the qualities of Monster Silk with additional strength derived from native spider silk. Kraig Biocraft Laboratories aims to address practical challenges in the textile market through innovative solutions and advanced genetic research.

Virgin Orbit, LLC is a vertically integrated space company based in Long Beach, California, and incorporated in 2016. As a subsidiary of Virgin.com Limited, it specializes in providing dedicated launch services for small satellites, catering to both commercial and government entities. The company operates the LauncherOne system, which offers flexible launch capabilities tailored specifically for small satellites. Virgin Orbit’s services encompass the delivery of satellites into orbit for a range of customers across various sectors, including commercial, civil, and national security. By focusing on democratizing access to space, Virgin Orbit aims to enhance opportunities for research, private astronaut flights, and satellite deployment, ultimately benefiting life on Earth.

Xos Trucks Inc. is an electric mobility company specializing in the development of electric commercial vehicle fleets and battery-electric vehicle platforms. Founded in 2016 and based in North Hollywood, California, Xos focuses on medium- and heavy-duty vehicles designed for last-mile delivery routes, typically under 200 miles per day. The company aims to assist commercial fleets in transitioning from diesel to zero-emission electric vehicles, offering similar performance with lower operating costs. Xos Trucks also designs electrified armored vehicles and delivers its products to markets in Texas and Illinois, with plans to expand to Michigan and New Jersey. Leveraging proprietary technologies, Xos provides fleets with vehicles that are not only environmentally friendly but also more efficient and easier to maintain compared to traditional internal combustion engine vehicles.

Romeo Power, Inc. is an energy technology company specializing in the design and manufacture of lithium-ion battery modules and packs specifically for commercial electric vehicles. Founded in 2015 and headquartered in Vernon, California, the company aims to facilitate sustainable transportation by offering energy-dense battery systems that provide superior performance, including enhanced acceleration, extended range, and improved safety. Romeo Power's product lineup includes Hermes modules tailored for trucks and buses, and the Brown Recluse, a passive cooling system that optimizes heat transfer and can be integrated into various vehicle configurations. The company’s solutions are customizable and scalable, supported by a proprietary battery management system that enhances the longevity and efficiency of its battery offerings.

Kraig Biocraft Laboratories, Inc. is a biotechnology company that specializes in the development of protein-based fibers through recombinant DNA technology. Founded in 2006 and based in Ann Arbor, Michigan, the company focuses on creating high-performance textiles for various commercial applications, particularly in the textile, specialty fiber, and technical textile industries. Its notable products include Monster Silk, which offers enhanced flexibility due to the natural elasticity of spider silk, and Dragon Silk, which combines the qualities of Monster Silk with additional strength derived from native spider silk. Kraig Biocraft Laboratories aims to address practical challenges in the textile market through innovative solutions and advanced genetic research.

Lordstown Motors is an automotive company focused on the development and manufacture of light-duty electric trucks aimed at fleet customers. The company operates engineering, research, and development facilities located in Farmington Hills, Michigan, and Irvine, California. Its flagship vehicle, the Endurance, is an all-electric pickup truck that is currently in the final design and testing phase at its facility in Lordstown, Ohio. As of now, the company has not yet launched a completed product to the market.

NLS Pharma is a clinical-stage drug development company focusing on neurobehavioral and neurocognitive disorders and their pharmacognosia. Its patient-centered approach increases the rate for success and our successful collaboration with experts across industry, academia allows for a target specific and customized approach.

Curetis AG, founded in 2015 and based in Holzgerlingen, Germany, develops molecular diagnostics solutions aimed at detecting infectious diseases, pathogens, and antibiotic resistance markers. The company specializes in multiparameter testing, enabling the simultaneous analysis of various analytes in a single run. Its primary focus is on providing comprehensive panels for detecting severe bacterial infections, offering rapid diagnostic solutions that help physicians obtain early and actionable insights in managing infectious diseases and antimicrobial resistance. Curetis operates as a subsidiary of OpGen, Inc. and is positioned to expand its diagnostic capabilities into other clinical applications beyond infectious diseases in the future.

Curetis AG, founded in 2015 and based in Holzgerlingen, Germany, develops molecular diagnostics solutions aimed at detecting infectious diseases, pathogens, and antibiotic resistance markers. The company specializes in multiparameter testing, enabling the simultaneous analysis of various analytes in a single run. Its primary focus is on providing comprehensive panels for detecting severe bacterial infections, offering rapid diagnostic solutions that help physicians obtain early and actionable insights in managing infectious diseases and antimicrobial resistance. Curetis operates as a subsidiary of OpGen, Inc. and is positioned to expand its diagnostic capabilities into other clinical applications beyond infectious diseases in the future.

Q BioMed Inc. is a biomedical acceleration and development company based in New York, founded in 2013. The company specializes in licensing and acquiring undervalued biomedical assets, providing strategic resources, developmental support, and capital to maximize their potential. Q BioMed is focused on enhancing therapeutic options in the life sciences and healthcare sectors. Its product offerings include Strontium Chloride SR89 and Metastron, both radiopharmaceuticals aimed at alleviating pain from bone cancer. Additionally, the company is developing several other candidates, such as Man-01 for primary open-angle glaucoma, QBM-001 for rare pediatric non-verbal autism spectrum disorder, and Uttroside-B for liver cancer. Q BioMed has also partnered with Mannin Research to develop novel therapeutics for Covid-19.

Future Farm Technologies Inc is an indoor plant growth technology company specializing in innovative solutions for vertical farming and LED lighting. The company focuses on enhancing agricultural productivity by utilizing advanced technologies to optimize plant growth in controlled environments. In addition to its core business in indoor farming, Future Farm also operates an ornamental plant greenhouse, contributing to its revenue primarily through the sale of nursery plants. The company is dedicated to providing sustainable food options with a focus on protein-rich products.

The largest taxi cab company doesn’t own a single car, the largest hotel has no real estate and the biggest restaurateur doesn’t run a single kitchen. MOI aims to be the largest “Spa/Salon”, “Barbershops” “Beauty” providers in the world without any rent, employees nor overhead. OpenTable & Grubhub Combined for the Beauty Industry; Browse, Book, Pay and Rate with the Swipe of a finger.MOI is an app allowing to connect in one place all the qualified spas salons and barbershops as well as freelance qualified and vetted artists and consumers. MOI is an online booking aggregator of hair spa and beauty services that connects salons barbershops nail salons, etc... looking for customers with customers looking for grooming locations or at home services. MOI is about to launch in New York City in August 2017 . MOI is looking forward to launching in more cities in the coming year. MOI Inc. expects to launch its smart phone app allowing individuals to identify and book beauty services while conveniently identifying the specific services needed, whether it’s is a full service shaving, hair and makeup by either a professional coming to them, or at any salon or barbershops in any given geographical area, starting with NY Metro as our launching market with more than 18,000 salons and 2,000 barbershops. The “MOI” App is effortless to use, exciting and necessary. We aim to benefit both providers on the app, as well as our subscribers to become the “go – to” platform for beauty and grooming services. The company is currently only focusing on the New York market and intend to be the principal app for the entire industry. in addition the company has a (point of sale) POS that is given for free to all salons interested in having a highly efficient system, this is the only develloped by a cosmetologist Elana B, understandng the indsurty needs, the POS created is allowing to save money on receptionists and making them true hosts, as well as managing the calendar, inventory, employees, and synchronizing all for free with the app increasing bookings by 25% on average. MOI is an ambitious and advanced system taking into account (B2B needs) and B2C requirements, with qualified providers. the Only booking app rewarding exising loyal clients and exposing providers to new customers daily. MOI is an outlier of all the companies out there because it was created and envisioned by an insider to the industry Elana B, contrary to all the other platform that are created by individuals that do not understand the needs of the providers and their relationships to their customers.Nor really understand that clients need taillored services and obejctive reviews.

Medivie Therapeutic Limited, founded in 2012 and based in Hemel Hempstead, United Kingdom, specializes in the development and marketing of dental support devices (DSDs) for various medical applications. The company offers Laboraide, a dental device designed to be used during childbirth, which helps relax the jaw, neck, and head muscles by facilitating oxygen flow. Additionally, Medivie is working on modular pacifiers aimed at supporting the development of mouth structure in children and preventing future damage to their gingival structure and teeth. The company’s products have potential applications in managing childbirth pain, migraines, chronic pain, and enhancing cognitive function. Medivie distributes its products through a network of distributors and online channels across Asia, Latin America, the United States, Europe, and Canada.

Neomedia Technologies Inc is a U.S.-based company specializing in the development of two-dimensional (2D) mobile barcode technology and services. The company focuses on enabling print and broadcast media to engage interactively with their audiences through the use of 2D barcodes, which simplify access to content by bypassing long URLs and cumbersome menus. Neomedia's solutions transform mobile devices with cameras into barcode scanners, facilitating a variety of applications in mobile marketing and commerce. By providing the necessary tools and infrastructure, Neomedia supports wireless carriers, brands, mobile phone manufacturers, and media companies in creating a reliable and universal optical messaging ecosystem, enhancing consumer engagement and delivering real-time content that users can easily carry on their mobile devices.

Oasmia Pharmaceutical AB specializes in the development and commercialization of innovative drugs for human and veterinary oncology, primarily in Sweden. The company focuses on creating novel formulations based on established cytostatics, aimed at enhancing efficacy and reducing side effects compared to existing treatments. Oasmia's portfolio includes Apealea/Paclical, which has completed phase III clinical trials for ovarian cancer, and Docetaxel micellar, a patented formulation in pre-clinical stages for prostate cancer. Additionally, it offers Doxophos, a formulation of doxorubicin used for various cancers, and KB9520, which is in pre-clinical development to mitigate side effects of cytostatic treatments. In the veterinary sector, Oasmia markets Paccal Vet and Doxophos Vet for mammary carcinoma and lymphoma, respectively. The company also possesses proprietary technologies, including XR-17, which enhances solubility for oncology applications. Founded in 1988 and headquartered in Uppsala, Sweden, Oasmia Pharmaceutical is committed to advancing cancer treatment through its research in nanotechnology and patented formulations.

Neomedia Technologies Inc is a U.S.-based company specializing in the development of two-dimensional (2D) mobile barcode technology and services. The company focuses on enabling print and broadcast media to engage interactively with their audiences through the use of 2D barcodes, which simplify access to content by bypassing long URLs and cumbersome menus. Neomedia's solutions transform mobile devices with cameras into barcode scanners, facilitating a variety of applications in mobile marketing and commerce. By providing the necessary tools and infrastructure, Neomedia supports wireless carriers, brands, mobile phone manufacturers, and media companies in creating a reliable and universal optical messaging ecosystem, enhancing consumer engagement and delivering real-time content that users can easily carry on their mobile devices.

Medicago Inc. is a biotechnology company based in Quebec City, Canada, specializing in the research, development, production, and commercialization of vaccines. The company employs proprietary plant-based manufacturing and Virus-Like Particle (VLP) technologies to create innovative vaccines and therapeutics aimed at infectious diseases and public health challenges. Medicago's product pipeline includes a candidate for the H5N1 pandemic influenza VLP vaccine, which has successfully completed a Phase I clinical trial, as well as an H1N1 VLP vaccine and seasonal influenza vaccines. The company has established collaboration agreements with organizations such as Viridis S.A. and Genopole biopark for the manufacturing of its vaccines, and with Philip Morris International to develop a therapeutic protein. Medicago was incorporated in 1997 and continues to focus on addressing emerging health threats through its advanced vaccine technologies.

Resverlogix Corp. is a late-stage clinical biotechnology company based in Calgary, Canada, focused on developing innovative therapeutics for various severe health conditions. The company's primary product, apabetalone, is a first-in-class small molecule and selective bromodomain and extra-terminal (BET) inhibitor currently undergoing Phase III clinical trials. This drug aims to address cardiovascular diseases, chronic kidney disease, neurodegenerative disorders, and diabetes, among other indications. In addition to apabetalone, Resverlogix is advancing several development programs, including technologies targeting vascular inflammation and Alzheimer's disease. The NexVas platform, which has progressed through initial safety trials, focuses on reducing cardiovascular risk by enhancing ApoA-I levels. Other research initiatives include therapeutics designed for use with medical devices and preclinical projects targeting severe proliferative diseases. Overall, Resverlogix is committed to addressing unmet medical needs in chronic conditions through its diverse pipeline of therapeutic candidates.

WILEX a biopharmaceutical company, develops drugs and diagnostic agents to detect cancer, treat malignant tumours, and prevent metastases. Its product line includes RENCAREX, a phase III substance for the treatment of non-metastatic renal cell cancer; REDECTANE, a phase III substance for the treatment of renal mass; and MESUPRON, a phase II substance for the treatment of pancreatic and breast cancer. The company's products also comprise the MEK inhibitor WX-554, which is under Phase I clinical trial; and the other oncology projects, including PI3K inhibitor WX-037 and three antibody programmes under preclinical development. It has a strategic alliance with UCB Pharma S.A. to develop preclinical oncology portfolio. The company was founded in 1997 and is headquartered in Munich, Germany.

Allon Therapeutics Inc. is a clinical-stage biotechnology company based in Vancouver, Canada, specializing in the development and marketing of therapies for central nervous system disorders. The company’s lead product, Davunetide, is currently undergoing Phase IIa clinical trials as an intranasal formulation for the treatment of Alzheimer's disease, schizophrenia-related cognitive impairment, and frontotemporal dementia. Additionally, Allon is evaluating an intravenous version of Davunetide in a separate Phase IIa trial for patients recovering from coronary artery bypass surgery. The company is also advancing AL-309, a preclinical candidate that has shown promise in animal models for conditions such as neuropathy and fetal alcohol syndrome. Allon Therapeutics collaborates with several research institutions, including the National Institute of Aging and Tel Aviv University, to further its research and development efforts.

Mobile Max Technologies Ltd specializes in developing and licensing unified communication solutions and mobile least cost routing technology for service providers, carriers, and IP/PBX providers in Israel. The company offers the MobileMax UC Suite, which enables carriers to deploy mobile applications featuring functionalities such as business and private calling, call forwarding, conference calling, and mobile VoIP services. Additionally, Mobile Max provides the MobileMax Server, a provisioning tool that customizes applications to meet specific customer needs and delivers them directly to users' mobile devices. Founded in 2004 and based in Tel Aviv, Mobile Max Technologies focuses on enhancing communication efficiency for its clients through innovative technology solutions.

Ashford Hospitality Trust is a real estate investment trust (REIT) that specializes in the hospitality sector, focusing primarily on full-service upscale and upper-upscale hotel properties across the United States. The company operates through its subsidiary, Ashford Hospitality Limited Partnership, which manages its assets. Ashford's business encompasses direct hotel investments, achieved through both acquisitions and new developments, as well as hotel financing, which involves owning subordinate hotel-related mortgages. The properties owned by Ashford operate under well-known brands such as Marriott, Hilton, Hyatt, Crowne Plaza, and Sheraton. In addition to its core hotel investments, Ashford provides real estate investment services, including mezzanine financing, first mortgage financing, and sales-leaseback transactions.

Hybrigenics Pharma is a bio-pharmaceutical company specializing in researching and developing new targets and therapies for cancer treatment. Their focus lies in studying Deubiquitinating Enzymes (DUBs) and the potential of patented DUB inhibitors in combating different cancer indications. Notably, the company has ceased the development of inecalcitol, a vitamin D receptor agonist.

Tower Semiconductor Ltd., operating under the brand name TowerJazz, is a global leader in specialty foundry services for semiconductor manufacturing. The company, along with its subsidiaries Jazz Semiconductor Inc. in the U.S. and TowerJazz Japan, Ltd., focuses on producing integrated circuits through a variety of customizable process technologies, including SiGe, BiCMOS, Mixed-Signal/CMOS, RFCMOS, CMOS Image Sensors, Power Management (BCD), and MEMS. TowerJazz supports a rapid and precise design cycle with its design enablement platform and offers Technology Optimization Process Services (TOPS) for integrated device manufacturers (IDMs) and fabless companies seeking to expand their production capacity. The company operates multiple fabrication facilities, located in Israel, the U.S., and Japan, providing clients with multi-fab sourcing options to meet diverse manufacturing needs.

VeriTeQ is a technology company based in Delray Beach, Florida, specializing in identification solutions for animals and emergencies. Founded in 1993, the company offers a range of products including FDA-approved implantable microchips for pet identification, visual and radio frequency identification (RFID) ear tags for livestock tracking, and GPS search and rescue beacons designed for use on aircraft, ships, and by outdoor enthusiasts. Additionally, VeriTeQ develops RFID technologies for identifying implantable medical devices utilized in radiation therapy and is creating a data analytics platform aimed at enhancing evidence-based healthcare through the collection of treatment regimen data.

Luminar Technologies, Inc. is a vehicle sensor and software company based in Orlando, Florida, founded in 2012. The company operates primarily in two segments: Autonomy Solutions and Other Component Sales. The Autonomy Solutions segment focuses on the design, manufacture, and sale of lidar sensors and related perception and autonomy software for original equipment manufacturers in the automotive and commercial vehicle sectors, including applications in robo-taxis. In addition, Luminar's Other Component Sales segment provides design, testing, and consulting services for non-standard integrated circuits aimed at government agencies and defense contractors. The company emphasizes enhancing safety and advancing autonomous technology in vehicles, particularly through advanced driver assistance systems that cater to a range of driving scenarios.